Skip to content

Clinical trials

Connective Tissue Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Connective Tissue Diseases Country / region: United States Clear all

94 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20012
20021
20033
20041
20052
20071
20082
20092
20102
20114
20123
20134
20142
20152
20161
20175
20184
20196
20202
20213
20225
20235
20246
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49
Recruiting13
Terminated11
Active, not recruiting9
Unknown status6
Enrolling by invitation4
Not yet recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)7
Eli Lilly and Company4
Viatris Innovation GmbH4
Bristol-Myers Squibb3
GlaxoSmithKline3
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)3
Amgen2
Caliway Biopharmaceuticals Co., Ltd.2
Children's Hospital Medical Center, Cincinnati2
Complexa, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Connective Tissue Diseases94
Arthritis25
Immune System Diseases24
Lupus Erythematosus, Systemic23
Autoimmune Diseases22
Rare Diseases17
Arthritis, Rheumatoid12
Scleroderma, Systemic12
Lung Diseases, Interstitial11
Pulmonary Arterial Hypertension10

Trials

Showing 1 to 25 of 94. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.